    
                        Pharmaceutical products
                    
                                Contract Value:
                                EUR 2M - 2M
                                Notice Type:
                                Contract award notice
                            
                                Published Date:
                                26 July 2021
                                Closing Date:
                                
                                Location(s):
                                        ES300 Madrid (ES Spain/ESPAÑA)
                            
                        Description:
                        
                        Suministro de medicamentos exclusivos: icatibant (Firazyr), inmunoglobulina humana inespecífica/hialuronidasa (Hyqvia), agalsidasa alfa (Replagal). Prórroga P.N.S.P. 44/2019
Suministro de medicamentos exclusivos: icatibant (Firazyr), inmunoglobulina humana inespecífica/hialuronidasa (Hyqvia), agalsidasa alfa (Replagal).
Suministro de medicamentos exclusivos: icatibant (Firazyr), inmunoglobulina humana inespecífica/hialuronidasa (Hyqvia), agalsidasa alfa (Replagal).

                                Awarded to:
                                        Takeda Farmacéutica España, S. A., Madrid (ES)
                            
                                 Download full details as .pdf
                        
                            The Buyer:
                            Servicio Madrileño de Salud, Hospital Universitario La Paz
                            
                            CPV Code(s):
                                33600000 - Pharmaceutical products